The European Health Interview Survey (EHIS) was launched in 2013 and contained some questions on the use of illicit drugs and NPS; however, the data was not reported to the EMCDDA by the end of 2016.
As far as national school surveys conducted in Luxembourg are concerned, comparable data from the Health Behaviour in School-aged Children (HBSC) show a decrease in the prevalence of any illicit drug use from 1999 to 2010 among students aged 12-18 years. In-depth analysis shows an overall decline in prevalence between 1999 and 2006 and a subsequent stabilisation, with the exception of cocaine, which has shown an increase, particularly in those aged 15-16 years.
Although cannabis remains the illicit drug most used by young people aged 12-18 years, a clear decline in lifetime prevalence of use has been observed since the start of this century. Last-year and last-month cannabis use prevalence rates declined substantially between 1999 and 2006, and appear to have stabilised since then.
Information on the use of NPS is available from the 2014 Eurobarometer. The data indicated that 7 % of 15- to 24-year-olds had used some kind of NPS in their lifetime, close to the European Union average of 8 %.
The Health Behaviour in School-aged Children study indicates an overall decline in illicit drug use among 12- to 18-year-olds between 1999 and 2006, and a subsequent stabilisation in illicit drug use levels, with the exception of cocaine
Studies reporting estimates of high-risk use can help to identify the extent of the more entrenched drug use problems, while data on the first-time entrants to specialised drug treatment centres, when considered alongside other indicators, can inform understanding on the nature and trends in high-risk drug use
The most recent estimate of high-risk drug use in Luxembourg dates back to 2007, when approximately 1 900 heroin users were reported. The prevalence rate of injection drug use in the national population aged 15-64 years was 5.7 per 1 000 population in 2009 and has remained stable since 2003. In recent years, a new trend of cocaine injecting has emerged in the country.
Data from specialised treatment centres indicate that most people enter treatment for primary use of opioids (mainly heroin) or cannabis. Slightly fewer than half of all opioid users entering treatment injected their primary illicit drug. The number of injectors among treatment clients has decreased over the past 10 years. Almost one quarter of heroin users entering treatment in 2015 were female
National estimates of last year prevalence of high-risk opioid use
NBYear of data 2015, or latest available year since 2009.
Characteristics and trends of drug users entering specialised drug treatment centres in Luxembourg
NBYear of data 2015. Data is for first-time entrants, except for gender which is for all treatment entrants.